New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders

  • ACS Med Chem Lett. 2017 Aug 17;8(9):908-910. doi: 10.1021/acsmedchemlett.7b00330.
Robert B Kargbo  1
Affiliations
  • 1. AMRI, Albany, New York 12212-5098, United States.
PMID: 28947934 DOI: 10.1021/acsmedchemlett.7b00330
Products